NSE/PGHH

PGHHProcter & Gamble Hygiene & Health Care

Consumer Goods · NSE

₹10,005+1.44%

52-wk low52-WEEK RANGE52-wk high

₹9,138+9.5% from low ·-30.5% from high₹14,397

Price chart · 1M–10Y · daily-close

NSE bhavcopy + 10Y historical

PGHH-27.48% · 1Y

Range high ₹14,543Range low ₹8,979Latest ₹10,005252 bars · daily-close · NSE bhavcopy + 10Y history

Consumer GoodsMidcap

Stock scorecard

Auto-computed from latest ratios + sector context · not a buy/sell signal

Composite50/100

Performance

—

Not enough price history to score.

Valuation

High

Looks expensive vs the sector.

· P/E 45.1 close to sector median 45.4
· P/B 34.62 above sector median

Growth

Medium

Steady but not standout growth.

· Revenue YoY +2.5% — slow
· Profit YoY +22.8%

Profitability

High

Showing good signs of profitability & efficiency.

· Net margin 19.2% — strong pricing power

DVM composite · Durability · Valuation · Momentum

Trendlyne-style 3-axis composite · all drivers shown below · not a buy/sell signal

CompositeC(57/100)

Durability

A+

95/100

Financially resilient — strong quality + solvency profile.

Show 3 drivers

Piotroski F-score7/8 (88pt)
Altman Z" score4.96 (100pt)
Debt/Equity0.00 (100pt)

Valuation

39/100

Trading at a premium — growth must keep delivering to justify.

Show 4 drivers

P/E vs sector (45.1 / 45.4)99% (61pt)
P/B34.62 (0pt)
Dividend yield2.35% (59pt)
EV/EBITDA27.0 (26pt)

Momentum

38/100

Momentum is muted; trend is unclear or rolling over.

Show 4 drivers

DMA-trend alignmentdown (25pt)
RSI (14)48.2 (60pt)
Price vs 200-DMA-20.2% (20pt)
MACD regimebullish (75pt)

Valuation positioning

Current ratio vs sector peer distribution

P/E (TTM)45.12

FAIR

CheapestP/E 45.1 near sector median.Most expensive

P/B34.62

OVERVALUED

CheapestP/B 34.62 at 85th %ile of sector.Most expensive

EV/EBITDA27.00

OVERVALUED

Monthly seasonality

Avg monthly return over 10 years · historical — not a forecast

Best: Sep +3.94% · Worst: Jan -2.33%

Jan

-2.3%

20% win

Feb

+1.1%

60% win

Mar

-2.0%

50% win

Apr

+1.0%

50% win

May

-1.6%

20% win

Jun

+2.2%

Monthly return distribution

Distribution of 120 monthly returns

Mean

+0.52%

Median

+0.74%

Std dev

5.18%

Best

+18.8%

Worst

-17.9%

% positive

55%

SWOT analysis

Auto-derived from ratios + sector context + forensics · research only, not a recommendation

STRENGTHS · 4

Lean balance sheet (D/E 0.00)
Low leverage means earnings are less sensitive to rate cycles
Strong net margin (19.2%)
High margin indicates pricing power + operating efficiency
Financial quality score 7/8
Piotroski ≥7 historically associated with outperformance
Bankruptcy risk low (Altman Z″ 4.96)
Z″ above 2.60 sits squarely in the 'safe' zone

WEAKNESSES · 0

No material weaknesses flag from the numbers

OPPORTUNITIES · 0

No strong near-term catalysts visible

THREATS · 0

No immediate threats from the data

RETURNS · DAILY-CLOSE BASED

3Y+ shown as CAGR

+1.4%

+2.2%

-4.9%

-20.5%

-29.1%

-27.8%

-10.1%

-4.9%

10Y

+4.4%

Peer	Last close	1Y change	Mcap ₹Cr	P/E	P/B	ROE	D/E	Rev YoY
PGHHTHIS Procter & Gamble Hygiene and Health Care Limited	₹10,005	-29.2%	32,238	45.1	34.62	—	0.00	+2.5%
HINDUNILVR Hindustan Unilever Limited	₹2,240.8	-4.7%	5,24,387	51.9	10.76	20.7%	0.04	+3.9%
ITC ITC Limited	₹306.8	-27.4%	3,82,149	18.8	5.38	28.7%	0.01	+6.7%
NESTLEIND Nestle India Limited	₹1,285.6	-46.4%	2,48,058	75.8	55.94	73.8%	0.11	+18.6%
ASIANPAINT Asian Paints Limited	₹2,464	+0.8%	2,41,259	62.7	12.32	19.6%	0.18	+3.7%
BRITANNIA Britannia Industries Limited	₹5,735.5	+6.3%	1,37,295	56.8	36.77	64.8%	0.58	+8.2%
GODREJCP Godrej Consumer Products Limited	₹1,109.4	-8.6%	1,13,048	61.9	9.29	15.0%	0.34	+8.8%
MARICO Marico Limited	₹757.3	+8.9%	98,411	57.3	24.30	—	0.14	+12.2%
DABUR Dabur India Limited	₹442.85	-6.9%	78,344	42.4	7.15	16.9%	0.12	+6.1%

ASK AXEL

Dig deeper into PGHH

Axel can fetch latest news, peer valuation, consensus estimates, insider activity, and concall commentary for PGHH — all in one sourced reply.

Ask free in chat

Run these tools on PGHH

Historical return →

"If I had bought PGHH in year X"

Rolling returns →

Worst/best 1/3/5/7/10-yr windows

Buy-the-dip backtester →

Dip-buying vs SIP on PGHH

Brokerage + charges →

All-in cost for trading PGHH

Research tool · not investment advice.

Axel Markets is an information + analytics product. We are not a SEBI-registered Research Analyst (RA) or Investment Adviser (IA). Nothing on this page is a buy, sell, or hold recommendation. Past performance is not indicative of future returns. Verify all data against the authoritative source (NSE, BSE, AMFI, SEBI, company RHP / factsheet) before acting. Daily OHLCV sourced primarily from our NSE bhavcopy ingest (public sec_bhavdata_full CSV), with Stooq as a fallback for historical gaps. Split + bonus adjusted. Excludes dividends. Not a recommendation. Past performance does not predict future returns. For authoritative live quotes see NSE / BSE directly.

Quarter	EPS estimate	EPS actual	Surprise %
-1q	77.90	92.87	+19.2%
-2q	72.70	64.65	-11.1%

Date	Amount
2026-02-05	₹195.00
2025-08-28	₹65.00
2025-02-20	₹110.00
2024-11-19	₹95.00
2024-02-09	₹160.00
2023-11-17	₹105.00
2023-02-08	₹80.00
2022-11-04	₹65.00
2022-02-08	₹95.00
2021-11-09	₹80.00
2021-05-11	₹150.00
2021-02-10	₹85.00
2020-11-13	₹105.00
2019-11-19	₹48.00
2019-02-15	₹40.00
2018-11-20	₹40.00
2017-11-07	₹27.00
2017-05-17	₹362.00
2016-11-24	₹36.00

Component	Ratio	Weight	Contribution
Working Capital / Total Assets (A)	0.100	×6.56	0.656
Retained Earnings / Total Assets (B)	0.164	×3.26	0.534
EBIT / Total Assets (C)	0.525	×6.72	3.531
Book Equity / Total Liabilities (D)	0.225	×1.05	0.236

Metric	2024-Q4	2025-Q1	2025-Q2	2025-Q3	2025-Q4
Revenue	1,246	989	935	1,149	1,260
Operating profit	361	199	257	275	392
OPM %	29.0%	20.1%	27.5%	24.0%	31.1%
Interest	7	6	0	4	3
Depreciation	—	10	—	—	—
PBT	364	213	265	282	402
Tax %	26.2%	26.6%	27.4%	25.5%	25.0%
Net profit	269	156	192	210	301
EPS (₹)	82.74	48.09	59.17	64.65	92.87

Metric	2021-FY	2022-FY	2023-FY	2024-FY
Revenue	3,570	3,792	3,905	4,192
Operating profit	858	794	824	949
OPM %	24.0%	20.9%	21.1%	22.6%
Interest	6	11	11	27
Depreciation	48	53	58	57
PBT	870	790	839	939
Tax %	25.1%	27.1%	19.2%	28.1%
Net profit	652	576	678	675
EPS (₹)	200.79	177.37	208.91	207.95

PGHHProcter & Gamble Hygiene & Health Care

Price chart · 1M–10Y · daily-close

Stock scorecard

DVM composite · Durability · Valuation · Momentum

Valuation positioning

Monthly seasonality

Monthly return distribution

SWOT analysis

Fundamentals

Peer comparison · Consumer Goods

Ask Axel about PGHH

Recent news

Dig deeper into PGHH

Run these tools on PGHH

Technical snapshot

Earnings history + surprises

Dividends + splits history

Recent news

Stock scorecard

SWOT analysis

DVM composite · Durability · Valuation · Momentum

Valuation positioning

Monthly seasonality

Monthly return distribution

Fundamentals

Pros and cons

Sector-relative context

Quality score · Piotroski F-score

Forensic score · Altman Z″ (emerging markets)

Quarterly results

Annual P&L

Balance sheet

Cash flow statement

Ratios

Peer comparison · Consumer Goods

Metric	2021-FY	2022-FY	2023-FY	2024-FY
Equity capital	32	32	32	32
Reserves	267	280	480	301
Borrowings	3	5	4	3
Other liabilities	—	—	—	-0
Total liabilities

Metric	2021-FY	2022-FY	2023-FY	2024-FY
CF Operating	863	573	826	471
CF Investing	7	-27	-10	1
CF Financing	-1,106	-569	-477	-862
Net cash flow	-236	-23	339	-390

Metric	2024-FY	2023-FY	2022-FY	2021-FY
OPM %	22.6%	21.1%	20.9%	24.0%
Net margin %	16.1%	17.4%	15.2%	18.3%
ROE %	159.5%	164.2%	187.9%	217.4%
ROCE %	226.5%	203.8%	257.9%	288.9%
Debt / Equity	0.01	0.01	0.02	0.01
Interest coverage	35.8×	74.8×	71.6×	143.4×
Revenue growth YoY	+7.3%	+3.0%	+6.2%	—
Profit growth YoY	-0.5%	+17.8%	-11.7%	—